BG
LLY icon

Bollard Group’s Eli Lilly LLY Stock Holding History

Bollard Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$98K Sell
200
-5,300
-96% -$5.42M ﹤0.01% 204
2026
Q1 		$951K Hold
5,500
– – 0.03% 113
2025
Q4 		$1.84M Hold
5,500
– – 0.05% 88
2025
Q3 		$523K Buy
+5,500
New +$4.09M 0.01% 134

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bollard Group's LLY Position: Q2 2026 in Review

Bollard Group increased its Eli Lilly (LLY) stake by 3.4% in Q2 2026, buying an estimated $6.63M and bringing the position to 197,160 shares worth $236M. The position accounts for 7.2% of the portfolio, ranked #3.

Bollard Group first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Bollard Group held 197,160 shares of Eli Lilly worth $236M as of Q2 2026.
  • Bollard Group bought 6,488 Eli Lilly shares in Q2 2026, an estimated $6.63M.
  • Eli Lilly made up 7.2% of Bollard Group's portfolio in Q2 2026, its #3 holding.
  • Bollard Group first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bollard Group's 13F filing for Q2 2026, filed 12 Aug 2026.